Italian Life Sciences Database

News in the Life Sciences Industry
Results 101 - 120 out of 149 displayed.
« 1 2 3 4 5 6 7 8 »

Nicox: Number of voting rights 31 May 2019

By: Nasdaq / GlobenewsWire - 03 Jun 2019

Related companies: NicOx Research Institute SRL | Nicox S.A. | Nicox Ophthalmics, Inc.

New cigarette filters block up to 60% of harmful substances thanks to Bio-on biopolymers

By: Nasdaq / GlobenewsWire - 03 Jun 2019

Related companies: Bio-on S.p.A.

Chung Yuan Christian University plans to lead delegation of Taiwanese startups eyeing Australian market

TAIPEI, Taiwan, June 3, 2019 /PRNewswire/ -- The Innovation & Incubation Center (IAIC), an arm of the Executive Operation Office for Industry-Academia Cooperation at Chung Yuan Christian University (CYCU) hosted the International Venture Capital Investment Match event on May 27, 2019. Over... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2019

Phase 3 trial of isatuximab combination therapy showed 40% reduction in the risk of disease progression or death for patients with relapsed/refractory multiple myeloma

By: Nasdaq / GlobenewsWire - 02 Jun 2019

Novo Nordisk A/S - Share repurchase programme

By: Nasdaq / GlobenewsWire - 29 May 2019

Menarini Ricerche at the ASCO Annual Meeting 2019 With Three Different Projects in Oncology

POMEZIA, Italy, May 23, 2019 /PRNewswire/ -- Menarini Ricerche will present three different projects related to the compounds in clinical development SEL24/MEN1703, MEN1611 and MEN1309/OBT076 at the ASCO Annual Meeting 2019 in Chicago.

By: PR Newswire Association LLC. - 23 May 2019

Related companies: Menarini Ricerche S.p.A.

Lundbeck increases its share capital by 26,098 shares (0.0131 % of outstanding shares) as a result of exercise of employee warrants

By: Nasdaq / GlobenewsWire - 22 May 2019

Information concerning the total number of voting rights and shares

By: Nasdaq / GlobenewsWire - 21 May 2019

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

By: Nasdaq / GlobenewsWire - 21 May 2019

B. Braun Interventional Systems Announces U.S. Commercial Launch of NuDEL™ All-in-One Stent Delivery System for Treatment of Congenital Heart Defects

By: Nasdaq / GlobenewsWire - 20 May 2019

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

By: Nasdaq / GlobenewsWire - 20 May 2019

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

By: Nasdaq / GlobenewsWire - 09 May 2019

Related companies: Recordati S.p.A | RECORDATI PHARMACEUTICALS LTD | Recordati Rare Diseases | Recordati Ireland Ltd.

Double-digit growth for all strategic brands and DKK 4,234 million in revenue and DKK 1,200 million in EBIT

By: Nasdaq / GlobenewsWire - 08 May 2019

Novo Nordisk A/S purchases B shares worth DKK 2,235 million from Novo Holdings A/S under the 2019 share repurchase programme

By: Nasdaq / GlobenewsWire - 07 May 2019

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Italy?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

October 2019
- Rennes: NutrEvent
- San Francisco: BIO Investor Forum
- Melbourne: Biotech-Pharma Product and Company Valuation - introduction

See Events »

Add an Event »

Latest company news

Novo Nordisk A/S – Share repurchase programme
14 Oct 2019 (Nasdaq / GlobenewsWire)

Johnson & Johnson Commits $500 Million Investment Over Four Years to Help End the Epidemics of HIV and Tuberculosis
11 Oct 2019 (PR Newswire Association LLC.)

Novo Nordisk A/S – Share repurchase programme
07 Oct 2019 (Nasdaq / GlobenewsWire)

News in the Life Sciences Industry

Nicox: Number of voting rights 31 May 2019

New cigarette filters block up to 60% of harmful substances thanks to Bio-on biopolymers

Chung Yuan Christian University plans to lead delegation of Taiwanese startups eyeing Australian market

Phase 3 trial of isatuximab combination therapy showed 40% reduction in the risk of disease progression or death for patients with relapsed/refractory multiple myeloma

Novo Nordisk A/S - Share repurchase programme

Menarini Ricerche at the ASCO Annual Meeting 2019 With Three Different Projects in Oncology

Lundbeck increases its share capital by 26,098 shares (0.0131 % of outstanding shares) as a result of exercise of employee warrants

Information concerning the total number of voting rights and shares

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

B. Braun Interventional Systems Announces U.S. Commercial Launch of NuDEL™ All-in-One Stent Delivery System for Treatment of Congenital Heart Defects

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

B. Braun Announces $1 Billion Investment to Alleviate IV Fluid Shortages in the U.S. Healthcare System

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2019

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Three-month interim report (Q1) 2019

SI-BONE, Inc. Reports First Quarter 2019 Financial Results

RECORDATI ANNOUNCES GROWTH IN THE FIRST QUARTER 2019. NEW THREE YEAR BUSINESS PLAN APPROVED

Double-digit growth for all strategic brands and DKK 4,234 million in revenue and DKK 1,200 million in EBIT

Novo Nordisk A/S purchases B shares worth DKK 2,235 million from Novo Holdings A/S under the 2019 share repurchase programme

Looking for companies outside of Italy?

Partners

Upcoming Life Sciences Events

Latest company news